A glyco-engineering approach for site-specific conjugation to Fab glycans
ABSTRACTEffective processes for synthesizing antibody-drug conjugates (ADCs) require: 1) site-specific incorporation of the payload to avoid interference with binding to the target epitope, 2) optimal drug/antibody ratio to achieve sufficient potency while avoiding aggregation or solubility problems...
Saved in:
Main Authors: | Maria L. Jaramillo (Author), Traian Sulea (Author), Yves Durocher (Author), Mauro Acchione (Author), Melissa J. Schur (Author), Anna Robotham (Author), John F. Kelly (Author), Marie-France Goneau (Author), Alma Robert (Author), Yuneivy Cepero-Donates (Author), Michel Gilbert (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage delivery
by: Loes van Schie, et al.
Published: (2023) -
Enzymatic glycan remodeling-metal free click (GlycoConnect™) provides homogenous antibody-drug conjugates with improved stability and therapeutic index without sequence engineering
by: Marloes A. Wijdeven, et al.
Published: (2022) -
Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment
by: Traian Sulea, et al.
Published: (2020) -
Extending the in vivo Half-Life of Adalimumab Fab via Sortase A-Mediated Conjugation of Adalimumab Fab with Modified Fatty Acids
by: Qing-Bin Zhang, et al.
Published: (2020) -
Targeted protein degradation through site-specific antibody conjugation with mannose 6-phosphate glycan
by: Kaori Mukai, et al.
Published: (2024)